Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

IntroductionChemotherapy-induced peripheral neuropathy (CIPN) can greatly impair function, leading to disability or truncated treatment in cancer patients. Previous animal studies show that cannabidiol (CBD) and delta-9- tetrahydrocannabinol (THC) can ameliorate CIPN. This study assessed the effect...

詳細記述

書誌詳細

主要な著者:	Marisa Weiss, Muath Giaddui, Stephanie Kjelstrom, Joseph Gary, Sara Jane Ward, Jessica Burrell, Katherine Diguilio, Gabrielle Bidas, Ebuwa Erebor, Sam Meske, Lisa Saeed, Sarah Windawi, Katherine Aliano Ruiz, Arezoo Ghaneie, Julianne Hibbs, John Marks, David Holtz, Zonera Ali, Aarthi Shevade, Jennifer Sabol, Robin Ciocca, Eric Zeger, Paul Gilman, Sharon Larson, Shoichi Shimamoto, Diana Martinez
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2025-10-01
シリーズ:	Frontiers in Oncology
主題:	chemotherapy-induced peripheral neuropathy cannabinoids cannabidiol (CBD) delta-9-tetrahydrocannabinol (THC) sensory impairment cancer
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1590168/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!